WOMEN are missing out on diagnosis of a potentially deadly heart condition which affects one in 500 people, says new research ...

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size.

Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL ...

Hypertrophic cardiomyopathy, or HCM, is a genetic disease in which the heart muscle grows thicker than normal. You might think of the term “big-hearted” to connote something good, says Dr ...

An initiative to improve care and standardize identification, assessment, referrals, and treatment for patients with HCM has been launched by the AHA.

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...

The findings show that, over a three-year period, children who received the standard treatment alone had an 80-per-cent ...

Newer therapies for multiple conditions were major stories this year, but long-term HF survival gains seem to have vanished.

Discover promising gene therapy results from Tenaya Therapeutics, Inc.'s TN-201 and TN-401 projects, potential impact on ...

After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...

Discover Trametinib as a promising treatment for severe hypertrophic cardiomyopathy in children with RASopathies.

Study warns of risks of intense training in young athletes: when does exercise benefit or harm children's hearts?